SCHEMBL863485

SCHEMBL863485

C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2nc1NCc1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 9/20 0.47
RECQL P46063 1/20 0.42
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
PIP4K2C Q8TBX8 4/20 0.38
GAA P10253 2/20 0.38
MAPK1 P28482 2/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
PIK3CG P48736 3/20 0.37
PIK3CA P42336 2/20 0.37
PIK3CB P42338 2/20 0.37
ABCB11 O95342 1/20 0.37
TBXA2R P21731 1/20 0.37
PIK3R1 P27986 1/20 0.37
HTR2A P28223 1/20 0.37
PDE3A Q14432 1/20 0.37
AURKA O14965 1/20 0.37
RPS6KB1 P23443 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL863486 1.00 PIK3CD (0.47) PIK3CDRECQLALDH1A1KDM4EHPGD
SCHEMBL863796 0.85 PIK3CD (0.46) PIK3CDALDH1A1KDM4EHPGDMAPK1
SCHEMBL863797 0.85 PIK3CD (0.46) PIK3CDALDH1A1KDM4EHPGDMAPK1
SCHEMBL864528 0.84 PIK3CD (0.45) PIK3CDLMNAPIK3CGPIK3CAPIK3CB
SCHEMBL864527 0.84 PIK3CD (0.45) PIK3CDLMNAPIK3CGPIK3CAPIK3CB
SCHEMBL864804 0.84 PIK3CD (0.49) PIK3CDKDM4EPIK3CGPIK3CAPIK3CB
SCHEMBL864803 0.84 PIK3CD (0.49) PIK3CDKDM4EPIK3CGPIK3CAPIK3CB
SCHEMBL863372 0.83 PIK3CD (0.54) PIK3CDPIK3CGPIK3CAPIK3CBABCB11
SCHEMBL863371 0.83 PIK3CD (0.54) PIK3CDPIK3CGPIK3CAPIK3CBABCB11
SCHEMBL863563 0.82 PIK3CD (0.48) PIK3CDPIK3CGPIK3CAPIK3CBABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396315-B1 QUINOLINE DERIVATIVES AS PI3K KINASE INHIBITORS UCB BIOPHARMA SPRL (BE) 2016-08-31 EP disclosed
US-8513284-B2 Fused pyridine and pyrazine derivatives as kinase inhibitors UCB PHARMA, S.A. (BE) 2013-08-20 US disclosed
US-20120077815-A1 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors UCB PHARMA S.A. (BE) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077815-A1 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors PDPK1, PDXK, PIK3CA PIK3CD 14/4885RECQL 549/4885ALDH1A1 3850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.